View Older Stories
-
Astera Labs (ALAB) PT Raised to $260 at Needham
-
Astera Labs (ALAB) PT Raised to $260 at Needham
-
Astera Labs (ALAB) PT Raised to $240 at BofA Securities
-
Astera Labs (ALAB) PT Raised to $270 at RBC Capital
-
Astera Labs, Inc. (ALAB) Tops Q1 EPS by 43c, provides guidance
-
Astera Labs ships 320-lane AI fabric switch to hyperscalers
-
Rothschild Redburn Starts Astera Labs (ALAB) at Neutral
-
Astera Labs (ALAB) PT Raised to $236 at Stifel
-
Northland: 'We are increasingly focused on AI edge opportunities, where the cycle is nascent, including AMBA, AMBQ, and SYNA'
-
Astera Labs (ALAB) PT Raised to $250 at RBC Capital
-
UBS Starts Astera Labs (ALAB) at Neutral
-
Citi Starts Astera Labs (ALAB) at Buy
-
RBC: 'Memory pricing strength could extend into 2027'
-
Credo Technology stock tumbles despite Nvidia message on copper
-
Loop Capital Starts Astera Labs (ALAB) at Buy; 'AI "Super-Cycle" + Increasing Complexity'
-
Credo Technology (CRDO) gains amid Broadcom results, pair trade unwind
-
Citi Opens Catalyst Watch oin These Names
-
Astera Labs, Inc. (ALAB) Tops Q4 EPS by 7c, Beats on Revenue; Offers Q1 Guidance
-
Astera Labs opens Israel design center for AI connectivity
-
RBC Capital Starts Astera Labs (ALAB) at Outperform
-
Astera Labs (ALAB) PT Raised to $195 at H.C. Wainwright
-
Mizuho's Klein on Astera Labs (ALAB): 'an over-reaction on fast money sellers...I like adding some ALAB here on 13% drop'
-
Stifel on Astera Labs (ALAB): 'fears are misplaced'
-
Morgan Stanley on Astera Labs (ALAB): 'AWS Trainium 4 unveiling points to new ALAB opportunities'
-
Top drug regulator Richard Pazdur set to leave FDA - Stat
-
Astera Labs announces custom connectivity solutions for AI infrastructure
-
Raymond James Assumes Astera Labs (ALAB) at Market Perform
-
BNP Paribas Exane Starts Astera Labs (ALAB) at Outperform
-
ALAB memory controllers featured in Microsoft Azure VMs preview
-
Astera Labs memory controllers now available on Microsoft Azure VMs
-
Northland Upgrades Astera Labs (ALAB) to Outperform, 'More Shots on Goal than Wayne Gretzky'
-
Astera Labs (ALAB) call put ratio 1.1 calls to 1 put as share price down 9.4%
-
Astera Labs (ALAB) PT Raised to $220 at Needham
-
Astera Labs (ALAB) call put ratio 1.2 calls to 1 put amid price movement
-
Astera Labs (ALAB) PT Lowered to $210 at BofA Securities
-
Astera Labs, Inc. (ALAB) Tops Q3 EPS by 36c, provides guidance
-
Astera Labs (ALAB) call put ratio 1.4 calls to 1 put as share price down 1.9%
-
Barclays turns more selective on AI chip stocks ahead of Q3 results
-
Barclays Downgrades Astera Labs (ALAB) to Equalweight
-
Astera Labs (ALAB) PT Raised to $185 at Stifel Strong Secular Growth, Record Revenue Outlook
-
Astera Labs joins Arm Total Design ecosystem for AI chiplet solutions
-
BofA Securities Starts Astera Labs (ALAB) at Neutral
-
Astera Labs (ALAB) Weakness Tied to Cautious Chatter
-
Astera Labs (ALAB) PT Raised to $275 at Citi, Opens 30-Day Upside Catalyst Watch
-
3 stocks set to benefit from AI scale-up networking boom: Morgan Stanley
-
Stifel Reiterates Buy Rating on Astera Labs (ALAB)
-
Astera Labs (ALAB) PT Raised to $215 at Evercore ISI
-
After-hours movers: AMD, Super Micro, SNAP, Match and more
-
Astera Labs, Inc. (ALAB) Tops Q2 EPS by 33c ; Offers Guidance
-
Astera Labs (ALAB) PT Raised to $145 at Stifel

